Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients. Rauma I, Mustonen T, Seppa JM, Ukkonen M, et al. J Neurol 2021 Jul 13. pii: 10.1007/s00415-021-10664.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rauma I, Mustonen T, Seppa JM, Ukkonen M, et al. Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients. J Neurol 2021 Jul 13. pii: 10.1007/s00415-021-10664.
PMID: 34255182